1. Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation. (9th December 2016) Authors: Vinnard, Christopher; Ravimohan, Shruthi; Tamuhla, Neo; Ivaturi, Vijay; Pasipanodya, Jotam; Srivastava, Shashikant; Modongo, Chawangwa; Zetola, Nicola M.; Weissman, Drew; Gumbo, Tawanda; Bisson, Gregory P. Journal: British journal of clinical pharmacology Issue: Volume 83:Number 4(2017:Apr.) Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗